Circadian rhythm of circulating glucose, insulin and growth hormone in spontaneously hypertensive rats

Increase in body weight of spontaneously hypertensive rats (SHR) under prolonged behavioral stimulation

We noticed that during 44 weeks of exposure to a number of behavioral tests (such as assessments of emotionality, locomotion, short term memory and visual discrimination learning) the body weight of spontaneously hypertensive rats (SHR) increased above that of normotensive controls (NT). To determine whether this difference was related to "behavioral stimulation" resulting from different testing situations and accompanying handling, body weights were recorded in other SHR and NT groups not subjected to any experiment (unstimulated). Stimulated SHR were significantly heavier than rats from other subgroups (unstimulated SHR as well as stimulated and unstimulated NT rats) which did not differ from one another. The first significant difference appeared after 7 weeks of behavioral training (18th week of life). Several weeks later, and continuing for the duration of study, stimulated SHR were approximately 12% heavier than the other 3 groups. No effect of behavioral testing on blood pressure was seen in either strain.

Altered hypothalamic monoamine metabolism and pituitary prolactin regulation in female spontaneously hypertensive rats

Prolactin (PRL) secretion after aromatic amino acid decarboxylase inhibition with NSD-1015 was significantly elevated in female spontaneously hypertensive rats (SHR) as compared to normotensive (WKY) controls. Although basal PRL levels tended to be elevated in SHR rats, the differences were not significant. In vitro PRL secretion was also significantly elevated in the SHR rats as compared to the WKY rats, but the SHR rats were more responsive to the inhibitory effects of dopamine (DA). Despite changes in pituitary PRL secretion and DA response, there was no apparent difference in tubero-infundibular DA activity between the two rat strains. Hypothalamic serotonin levels were elevated in SHR rats, but metabolism did not appear to be significantly changed based on measurements of 5-hydroxytryptophan accumulation after NSD-1015 treatment.